Clinical trial
Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment
NCT05858203 is registered in ClinicalTrials.gov with Regina Elena Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment
- Lead sponsor
- Regina Elena Cancer Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 22, 2020
- Completion date
- December 31, 2025
- Enrollment
- 150 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.